-

Feinstein Institutes’ Dr. Ping Wang Receives 2023 Mentor Award From the Shock Society

MANHASSET, N.Y.--(BUSINESS WIRE)--Sepsis makes up nearly a quarter of deaths worldwide, often leading to shock and multiple organ failure. Ping Wang, MD, an investigator at The Feinstein Institutes for Medical Research, has dedicated his career to sepsis research and is being rewarded with the Shock Society Mentor Award for his leadership and mentoring of young clinicians and basic researchers at the US Shock Society’s 46th annual Conference on Shock last month in Portland, OR.

The Shock Society Mentor Award annually honors a member of the Shock Society for excellence in mentoring trainees and junior faculty. This award is given to an individual who has had a significant impact as a mentor in promoting professional development and career advancement of the next generation of basic scientists and clinician-scientists in shock research.

Dr. Wang – chief scientific officer and senior vice president at the Feinstein Institutes – is also a professor and chairman of the Department of Molecular Medicine and vice chairman for research at the Department of Surgery at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. He has dedicated his three-decade career to sepsis and shock research to identify its molecular mechanisms and potential therapeutic drug targets, while also mentoring more than 100 surgical residents, PhD students, postdoctoral researchers and research scientists.

As a mentor, he has helped students and trainees develop critical thinking skills, enhance their scientific knowledge and hone their research skills to make them highly competent professionals in shock research. His support and training have led to numerous successes that include publications, awards and grants from the National Institutes of Health.

“It is an honor to be recognized by the Shock Society for my passion, commitment and support of young researchers,” said Dr. Wang. “Sepsis and shock continue to challenge clinicians and scientists on how to best identify and treat the condition. It is our responsibility to educate, train and mentor the future generation of clinician-scientists who will advance our understanding of the often-fatal diseases.”

Dr. Wang is an internationally recognized leader in sepsis and shock research. He served as president of the Shock Society from 2016-2017 and was program chair at the 2013 Conference on Shock. The Shock Society is a collective group whose mission is to improve the care of victims of trauma, sepsis and shock by promoting clinically relevant research. His research goals and lab help us understand the pathobiological mechanisms contributing to organ dysfunction and to develop better therapies for inflammatory diseases such as sepsis, ischemia-reperfusion injury and shock.

Dr. Wang recently led new research that discovered a protein which inhibits the body’s ability to clear bacteria. The study explored how extracellular cold-inducible RNA-binding protein (eCIRP) causes immune dysfunction, and how it disrupts the cells within the immune system, which ingest bacteria and secrete both pro-inflammatory and antimicrobial mediators. Dr. Wang and co-principal investigators also recently received $3.8 million from the National Institute of Health to study sepsis and radiation exposure.

About the Feinstein Institutes

The Feinstein Institutes for Medical Research is the home of the research institutes of Northwell Health, the largest health care provider and private employer in New York State. Encompassing 50 research labs, 3,000 clinical research studies and 5,000 researchers and staff, the Feinstein Institutes raises the standard of medical innovation through its five institutes of behavioral science, bioelectronic medicine, cancer, health system science, and molecular medicine. We make breakthroughs in genetics, oncology, brain research, mental health, autoimmunity, and are the global scientific leader in bioelectronic medicine – a new field of science that has the potential to revolutionize medicine. For more information about how we produce knowledge to cure disease, visit http://feinstein.northwell.edu and follow us on LinkedIn

Contacts

Julianne Mosher Allen
516-880-4824
jmosherallen@northwell.edu

The Feinstein Institutes for Medical Research


Release Versions

Contacts

Julianne Mosher Allen
516-880-4824
jmosherallen@northwell.edu

More News From The Feinstein Institutes for Medical Research

Feinstein Institutes Awarded $8.9M for Care Planning Program in Older Adults and Those With Dementia

MANHASSET, N.Y.--(BUSINESS WIRE)--Northwell Health’s Feinstein Institutes for Medical Research aims to transform advanced care planning for older adults and those with Alzheimer’s disease and related dementias. The Feinstein Institutes secured a multi-year $8.9 million grant from the National Institutes of Health’s (NIH) National Institute on Aging (NIA) and will collaborate with Tufts University and Dartmouth Health to conduct the Advancing Ethical Goals in Society (AEGIS) clinical trial. This...

Cancer Cases Explode Among WTC Health Patients, Underscores Ongoing Crisis 25 Years After 9/11

NEW HYDE PARK, N.Y.--(BUSINESS WIRE)--Twenty-five years after the World Trade Center terror attack on September 11, 2001, physicians and patients gathered at Northwell’s Long Island Jewish (LIJ) Medical Center to commemorate the grim anniversary and to sound the alarm to an ongoing health crisis. The past is prologue for a slow-motion health disaster as cancer cases have exploded among some of the approximately 145,000 people currently enrolled in the World Trade Center (WTC) Health Program, wh...

Feinstein Institutes’ researchers find jumping genes at the center of blood immune networks disrupted in schizophrenia

MANHASSET, N.Y.--(BUSINESS WIRE)--Unlocking a crucial piece of schizophrenia’s molecular puzzle, scientists at Northwell Health’s Feinstein Institutes for Medical Research have found that jumping genes, also known as transposable elements, are linked to a communication breakdown in the blood gene expression networks of people living with schizophrenia. Jumping genes are DNA sequences from ancient viruses and other elements that could once move around the human genome – and in rare cases still c...
Back to Newsroom